INVESTORS
NEWSROOM
Responsibility
SUBSCRIBE
CONSUMERS
HEALTHCARE PROFESSIONALS
CAREERS
ABOUT ABBOTT
Another outstanding year of performance positions us well for the year ahead.
That’s a wrap for 2018! Thanks to strong execution and more than 30 significant product advances that made a big impact on people’s lives, Abbott had another outstanding year.
Most notably, we delivered strong double-digit underlying growth and grew more than 7 percent on an organic basis. We also generated strong operating cash flow, paid down more than $8 billion of debt, returned $2 billion to shareholders and announced a 14.3 percent increase in our quarterly common dividend.
And we expect 2019 to be another great year. We issued full-year adjusted earnings-per-share guidance of $3.15 to $3.25 ($1.80 to $1.90 on a GAAP basis) and continue to launch breakthrough technologies to fuel growth for years to come.
Some of the hottest areas we’re working on are in our diagnostics and devices businesses, including:
For full details on our 2018 performance, you can read our press release, or take a look at some additional materials below:
Abbott's Chairman and CEO Miles D. White shared his views on full-year performance:
Learn more about Abbott’s full-year 2018 results:
Download a summary of Abbott's earnings highlights here.
For more information on Abbott's earnings results, see the news release.